Compare Davita Inc (DVA) vs Johnson & Johnson (JNJ) Price & Performance

Davita IncTrade

Johnson & JohnsonTrade

Price performance (Past 24H)

Key statistics

Davita Inc vs Johnson & Johnson — how do they compare? Davita Inc trades at $179.02 (market cap $11.38B), while Johnson & Johnson trades at $258.91 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 55× Davita Inc's market cap, and Johnson & Johnson pays a 2.06% dividend while Davita Inc pays none. Which is the better fit depends on your goals.

	DVA	JNJ
Market Cap	$11.38B	$626.09B
Sector	Health	Health
52-Week High	$240.96	$267.24
52-Week Low	$103.87	$172.78
Enterprise Value	$24.10B	$654.37B
Volume	—	6,156,228
Dividend Yield	—	2.06%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DVA

Berkshire Hathaway cuts cash reserves, boosts stock buybacks and equity investments under new CEO Greg Abel.CNBC · 3 days agoBullish View details →

JNJ

Invesco's PEY ETF outperforms with a dividend-growth filter, offering higher returns and reliable income.24/7 Wall Street · 18 hours agoBullish Johnson & Johnson stock holds near 52-week high; growth strong but valuation pricey, patience advised.24/7 Wall Street · 21 hours agoNeutral Fidelity Dividend ETF's payout is safe but not ideal for steady income due to variable quarterly dividends.24/7 Wall Street · 22 hours agoNeutral View details →

About Davita Inc

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.